Gain Therapeutics reported net income of -$4.68M for the quarter ended Jun 2026. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 11.88M | 11.88M | 11.88M | 11.88M | 11.88M | 11.88M | 12.09M | 12.63M | 12.78M | 13.01M | 18.04M | 19.22M | 25.96M | 27.13M | 28.75M | 30.77M | 35.98M | 32.97M | 42.49M | 43.34M | ||||||
| Revenue & cost | ||||||||||||||||||||||||||
| Revenue | 0.03M | 0.04M | 0.05M | 0.10M | 0.06M | |||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||
| Research & DevelopmentR&D | 2.48M | 1.47M | 1.56M | 2.58M | 1.96M | 2.27M | 2.79M | 3.99M | 2.37M | 2.37M | 2.51M | 4.44M | 2.62M | 1.22M | 2.26M | 2.76M | 2.85M | 2.35M | 2.76M | 2.14M | ||||||
| Selling, General & AdministrativeSG&A | 2.19M | 1.78M | 1.78M | 2.69M | 2.79M | 2.29M | 2.49M | 3.74M | 2.52M | 2.03M | 1.87M | 3.75M | 1.84M | 2.11M | 2.11M | 2.33M | 1.94M | 2.12M | 2.59M | 2.54M | ||||||
| Operating ExpensesOpex | 4.66M | 3.25M | 3.33M | 5.27M | 4.75M | 4.56M | 5.28M | 7.73M | 4.89M | 4.41M | 4.38M | 8.18M | 4.46M | 3.33M | 4.37M | 5.09M | 4.79M | 4.47M | 5.35M | 4.68M | ||||||
| Operating IncomeOp. Inc | -4.64M | -3.21M | -3.29M | -5.18M | -4.75M | -4.56M | -5.23M | -7.73M | -4.89M | -4.41M | -4.38M | -8.18M | -4.46M | -3.33M | -4.37M | -5.09M | -4.79M | -4.47M | -5.35M | -4.68M | ||||||
| EBIT | -4.64M | -3.21M | -3.29M | -5.18M | -4.75M | -4.56M | -5.23M | -7.73M | -4.89M | -4.41M | -4.38M | -8.18M | -4.46M | -3.33M | -4.37M | -5.09M | -4.79M | -4.47M | -5.35M | -4.68M | ||||||
| Non-operating items | ||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.12M | 0.08M | 0.11M | 0.05M | 0.04M | 0.04M | 0.08M | 0.08M | 0.09M | 0.06M | ||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.03M | -0.02M | 0.02M | 0.04M | 0.04M | -0.20M | -0.04M | -0.06M | 0.08M | -0.41M | 0.27M | -0.04M | -0.12M | 0.02M | -0.10M | -0.62M | -0.03M | -0.08M | -0.17M | 0.05M | ||||||
| Net income details | ||||||||||||||||||||||||||
| EBT | -4.66M | -3.23M | -3.27M | -5.08M | -4.55M | -4.60M | -5.12M | -7.66M | -4.70M | -5.00M | -3.99M | -8.14M | -4.47M | -5.78M | -4.43M | -5.67M | -4.74M | -7.64M | -5.43M | -4.57M | ||||||
| Tax ProvisionsTaxes | 0.01M | -0.01M | 0.00M | 0.01M | 0.00M | 0.08M | 0.02M | 0.03M | 0.02M | 0.01M | 0.02M | 0.00M | 0.01M | 0.50M | 0.10M | 0.14M | 0.55M | -4.84M | 0.18M | 0.10M | ||||||
| Profit After TaxPAT | -4.66M | -3.22M | -3.27M | -5.09M | -4.56M | -4.67M | -5.14M | -7.69M | -4.72M | -4.72M | -4.01M | -8.14M | -4.49M | -3.77M | -4.53M | -5.81M | -5.28M | -4.54M | -5.61M | -4.68M | ||||||
| Income from Non-Controlling InterestsInc. Minority | 0.01M | 0.01M | 0.01M | |||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -4.66M | -3.22M | -3.27M | -5.09M | -4.56M | -4.67M | -5.14M | -7.69M | -4.72M | -5.01M | -4.01M | -8.14M | -4.49M | -6.28M | -4.53M | -5.81M | -5.28M | -2.80M | -5.61M | -4.68M | ||||||
| Consolidated Net IncomeConsol Net Inc. | -4.66M | -3.22M | -3.27M | -5.09M | -4.56M | -4.67M | -5.14M | -7.69M | -4.72M | -5.01M | -4.01M | -8.14M | -4.49M | -6.28M | -4.53M | -5.81M | -5.28M | -2.80M | -5.61M | -4.68M | ||||||
| Income towards Parent CompanyParent Net Inc | -4.66M | -3.22M | -3.27M | -5.09M | -4.56M | -4.67M | -5.14M | -7.69M | -4.72M | -5.01M | -4.01M | -8.14M | -4.49M | -6.28M | -4.53M | -5.81M | -5.28M | -2.80M | -5.61M | -4.68M | ||||||
| Net Income towards Common StockholdersNet Income | -4.66M | -3.22M | -3.27M | -5.09M | -4.56M | -4.67M | -5.14M | -7.69M | -4.72M | -5.01M | -4.01M | -8.14M | -4.49M | -6.28M | -4.53M | -5.81M | -5.28M | -2.80M | -5.61M | -4.68M | ||||||
| Additional items | ||||||||||||||||||||||||||
| EPS (Basic) | -0.39 | -0.32 | -0.28 | -0.43 | -0.38 | -0.39 | -0.43 | -0.62 | -0.37 | -0.39 | -0.22 | -0.42 | -0.17 | -0.27 | -0.16 | -0.19 | -0.15 | -0.08 | -0.13 | -0.11 | ||||||
| EPS (Diluted) | -0.39 | -0.32 | -0.28 | -0.43 | -0.38 | -0.39 | -0.43 | -0.62 | -0.37 | -0.39 | -0.22 | -0.42 | -0.17 | -0.27 | -0.16 | -0.19 | -0.15 | -0.08 | -0.13 | -0.11 | ||||||
| Shares Outstanding | 11.88M | 10.17M | 11.88M | 11.88M | 11.88M | 11.88M | 11.94M | 12.39M | 12.70M | 13.01M | 17.98M | 19.22M | 26.53M | 22.88M | 28.69M | 30.34M | 35.00M | 32.97M | 42.23M | 42.88M | ||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 11.88M | 10.17M | 11.88M | 11.88M | 11.88M | 11.88M | 11.94M | 12.39M | 12.70M | 13.01M | 17.98M | 19.22M | 26.53M | 22.88M | 28.69M | 30.34M | 35.00M | 32.97M | 42.23M | 42.88M | ||||||
| EBITDA | -4.64M | -3.21M | -3.29M | -5.18M | -4.75M | -4.56M | -5.23M | -7.73M | -4.89M | -4.41M | -4.38M | -8.18M | -4.46M | -3.33M | -4.37M | -5.09M | -4.79M | -4.47M | -5.35M | -4.68M | ||||||
| Tax Rate | -0.11 | 0.26 | -0.05 | -0.18 | -0.09 | -1.70 | -0.33 | -0.35 | -0.46 | -0.29 | -0.50 | -0.01 | -0.25 | -8.74 | -2.28 | -2.49 | -11.60 | 63.37 | -3.37 | -2.28 |